Lazo JS - Search Results

1

Development and validation of a high-content screening assay to identify inhibitors of cytoplasmic dynein-mediated transport of glucocorticoid receptor to the nucleus.

Johnston PA, Shinde SN, Hua Y, Shun TY, Lazo JS, Day BW. Johnston PA, et al. Among authors: lazo js. Assay Drug Dev Technol. 2012 Oct;10(5):432-56. doi: 10.1089/adt.2012.456. Epub 2012 Jul 25. Assay Drug Dev Technol. 2012. PMID: 22830992 Free PMC article.

2

Antimitotic actions of a novel analog of the fungal metabolite palmarumycin CP1.

Lazo JS, Tamura K, Vogt A, Jung JK, Rodriguez S, Balachandran R, Day BW, Wipf P. Lazo JS, et al. J Pharmacol Exp Ther. 2001 Feb;296(2):364-71. J Pharmacol Exp Ther. 2001. PMID: 11160619

3

The antisignaling agent SC-alpha alpha delta 9, 4-(benzyl-(2-[(2,5-diphenyloxazole-4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric acid, is a structurally unique phospholipid analogue with phospholipase C inhibitory activity.

Vogt A, Pestell KE, Day BW, Lazo JS, Wipf P. Vogt A, et al. Among authors: lazo js. Mol Cancer Ther. 2002 Sep;1(11):885-92. Mol Cancer Ther. 2002. PMID: 12481409

4

Redox regulation of Cdc25B by cell-active quinolinediones.

Brisson M, Nguyen T, Wipf P, Joo B, Day BW, Skoko JS, Schreiber EM, Foster C, Bansal P, Lazo JS. Brisson M, et al. Among authors: lazo js. Mol Pharmacol. 2005 Dec;68(6):1810-20. doi: 10.1124/mol.105.016360. Epub 2005 Sep 9. Mol Pharmacol. 2005. PMID: 16155209

5

Systems cell biology knowledge created from high content screening.

Giuliano KA, Cheung WS, Curran DP, Day BW, Kassick AJ, Lazo JS, Nelson SG, Shin Y, Taylor DL. Giuliano KA, et al. Among authors: lazo js. Assay Drug Dev Technol. 2005 Oct;3(5):501-14. doi: 10.1089/adt.2005.3.501. Assay Drug Dev Technol. 2005. PMID: 16305307

6

Synthesis and biological activity of a focused library of mitogen-activated protein kinase phosphatase inhibitors.

Arnold DM, Foster C, Huryn DM, Lazo JS, Johnston PA, Wipf P. Arnold DM, et al. Among authors: lazo js. Chem Biol Drug Des. 2007 Jan;69(1):23-30. doi: 10.1111/j.1747-0285.2007.00474.x. Chem Biol Drug Des. 2007. PMID: 17313454

7

Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatases.

Vogt A, Lazo JS. Vogt A, et al. Among authors: lazo js. Methods. 2007 Jul;42(3):268-77. doi: 10.1016/j.ymeth.2007.02.006. Methods. 2007. PMID: 17532514 Free PMC article.

8

Development and optimization of high-throughput in vitro protein phosphatase screening assays.

Tierno MB, Johnston PA, Foster C, Skoko JJ, Shinde SN, Shun TY, Lazo JS. Tierno MB, et al. Among authors: lazo js. Nat Protoc. 2007;2(5):1134-44. doi: 10.1038/nprot.2007.155. Nat Protoc. 2007. PMID: 17546004

9

Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors.

Johnston PA, Foster CA, Shun TY, Skoko JJ, Shinde S, Wipf P, Lazo JS. Johnston PA, et al. Among authors: lazo js. Assay Drug Dev Technol. 2007 Jun;5(3):319-32. doi: 10.1089/adt.2007.066. Assay Drug Dev Technol. 2007. PMID: 17638532

10

Development and implementation of a miniaturized high-throughput time-resolved fluorescence energy transfer assay to identify small molecule inhibitors of polo-like kinase 1.

Sharlow ER, Leimgruber S, Shun TY, Lazo JS. Sharlow ER, et al. Among authors: lazo js. Assay Drug Dev Technol. 2007 Dec;5(6):723-35. doi: 10.1089/adt.2007.102. Assay Drug Dev Technol. 2007. PMID: 18181689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters